GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort study.

Nelson RA, Lai YC, Kil SH, Lee HS, Mortimer J, Wang PH.

Open source

DOI
10.1093/oncolo/oyag268
Published
2026-07-01
Container
Oncologist
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyag268,
  title = {GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort study.},
  author = {Nelson RA and  Lai YC and  Kil SH and  Lee HS and  Mortimer J and  Wang PH.},
  year = {2026},
  journal = {Oncologist},
  doi = {10.1093/oncolo/oyag268},
  url = {https://doi.org/10.1093/oncolo/oyag268}
}

RIS

TY  - JOUR
TI  - GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort study.
AU  - Nelson RA
AU  -  Lai YC
AU  -  Kil SH
AU  -  Lee HS
AU  -  Mortimer J
AU  -  Wang PH.
PY  - 2026
JO  - Oncologist
DO  - 10.1093/oncolo/oyag268
UR  - https://doi.org/10.1093/oncolo/oyag268
ER  - 

APA

RA, N., YC, L., SH, K., HS, L., J, M., & PH., W. (2026). GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort study.. Oncologist. https://doi.org/10.1093/oncolo/oyag268

Source records